Cwestiwn ysgrifenedig WQ99146

Cancer is one of the most significant health challenges facing Wales and is a central priority for this government. We have started work on the development of a National Cancer Plan and will be issuing a Written Statement before the end of this term.

Cancer waiting times are addressed through the intervention and support mechanisms of the oversight and escalation framework for NHS Wales. Improvement and performance is also supported by NHS Wales Performance & Improvement.

While Cwm Taf Morgannwg UHB was de-escalated to level 1 for cancer performance in February 2026; we recognise the areas of significant challenge within the health boards, including the provision of histopathology services which is especially affecting Swansea Bay UHB who also provide some services to Cwm Taf Morgannwg UHB. Swansea Bay UHB are introducing mitigating actions, including the outsourcing of some services to help speed up access to diagnostic tests and results. These actions should help improve overall performance within the health board.

Both organisations are continuing to improve the operational delivery of clinical pathways while also addressing longer-term service design.

Swansea Bay UHB currently remains in level 4 escalation for performance and outcomes for cancer. The de-escalation criteria states the health board must achieve a performance of at least 60% and sustain this improvement for at least three consecutive months. Further details are included in the most recent Swansea Bay UHB escalation framework published on the Welsh Government website.